So, we created an immune-related 3-gene (CDADC1, ENC1, PIM1) index (IRPI), an independent prognostic factor among multiple clinical characteristics, and found that it could predict OS and PFS of HER2+BC patients. The gene discussed is ENC1; the disease is breast cancer.